Triglyceride lowering drugs: not just icosapent ethyl
- PMID: 32154875
- DOI: 10.1093/eurheartj/ehaa075
Triglyceride lowering drugs: not just icosapent ethyl
Comment in
-
Triglyceride reduction in secondary atherosclerotic cardiovascular disease prevention: core concepts in contemporary therapeutic targeting.Eur Heart J. 2020 Apr 14;41(15):1521-1522. doi: 10.1093/eurheartj/ehaa078. Eur Heart J. 2020. PMID: 32154871 No abstract available.
Comment on
-
Real-world risk of cardiovascular outcomes associated with hypertriglyceridaemia among individuals with atherosclerotic cardiovascular disease and potential eligibility for emerging therapies.Eur Heart J. 2020 Jan 1;41(1):86-94. doi: 10.1093/eurheartj/ehz767. Eur Heart J. 2020. PMID: 31733058
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
